E-ISSN: 1305-3612
Association of pulmonary artery obstruction index with elevated heart-type fatty acid binding protein and short-term mortality in patients with pulmonary embolism at intermediate risk
PDF
Cite
Share
Request
Chest Imaging - Original Article
VOLUME: 18 ISSUE: 6
P: 531-536
November 2012

Association of pulmonary artery obstruction index with elevated heart-type fatty acid binding protein and short-term mortality in patients with pulmonary embolism at intermediate risk

Diagn Interv Radiol 2012;18(6):531-536
DOI: 10.4261/1305-3825.DIR.5827-12.3
Enes Elvin Gül 1
İlknur Can 2
İbrahim Güler 3
Ahmet Yeşildağ 4
Turyan Abdülhalikov 2
Mehmet Kayrak 5
Kurtuluş Özdemir 2
Hasan Gök 2
1. Departments of Hematology, Selçuk University Meram School of Medicine, Meram, Konya, Turkey
2. Departments of Cardiology, Konya University Meram School of Medicine, Konya, Turkey
3. Department of Radiology, Selcuk University Faculty of Medicine, Konya, Turkey
4. Department of Radiology , Süleyman Demirel University Faculty of Medicine, İsparta, Turkey
5. Departments of Radiology, Selçuk University Meram School of Medicine, Meram, Konya, Turkey
No information available.
No information available
Received Date: 16.03.2012
Accepted Date: 13.06.2012
PDF
Cite
Share
Request

ABSTRACT

PURPOSE

Heart-type fatty acid binding protein (H-FABP) is a sensitive marker of myocardial injury and predictor of worse prognosis in patients with pulmonary embolism (PE). Assessment of right ventricular dysfunction and pulmonary artery obstruction index (PAOI) with computed tomography (CT) has been reported as a predictor of mortality in PE. Therefore, we aimed to assess the correlation between H-FABP and CT angiographic PAOI in PE patients at intermediate risk.

MATERIALS AND METHODS

Sixty-one patients (28 males; mean age, 62±17 years) with diagnosis of PE were included in this study. CT was performed in all patients, and the following parameters were evaluated: right ventricle/left ventricle ratio (RV/LV), pulmonary artery axial diameter, superior vena cava axial diameter, and PAOI determined with Qanadli score. Blood samples were assessed for H-FABP and troponin levels. Patients were followed for 30 days after discharge.

RESULTS

Mean PAOI was 57±18%. Eleven patients died during the follow-up period due to PE (18% mortality rate). H-FABP was positive in 21 patients (35%). There was no difference in CT parameters between patients with positive H-FABP and negative H-FABP. In addition, CT parameters were similar between patients who survived and those who did not. RV/LV ratio correlated with PAOI score. Among the biomarkers, troponin levels correlated with both RV/LV ratio and PAOI. H-FABP was an independent predictor of mortality. PAOI and RV/LV ratio did not predict 30-day mortality.

CONCLUSION

Although H-FABP positivity confers a bad prognosis on PE patients at intermediate risk, PAOI did not predict mortality in this group.